ChinaBio Today -- Hainan Honz Pharmaceutical Co. staged its IPO on the Shenzhen GEM exchange this week, raising 1.5 billion RMB ($238 million) by selling 25 million shares at a price of 60 RMB ($8.80) each. The company, which is a major maker of pediatric drugs, is the first company from Hainan to list on the exchange. In open market trading, Hainan Honz fell slightly to 59.88 RMB ($8.67). More details...
